1. Background {#sec143296}
=============

Children who undergo cardiac surgery for congenital heart diseases are high risk for significant post-operative morbidity and mortality. The improvement in pediatric intensive care, results in better survival in such patients([@A30391R1]-[@A30391R7]). The duration of mechanical ventilation (MV) is one of the most important clinical factors which predicts outcomes in pediatric cardiac surgery ([@A30391R1]-[@A30391R13]).The improvement in MV protocols and early extubation shortens the intensive care unit (ICU) stay and results in less complications and improved outcomes ([@A30391R14]-[@A30391R16]) .Hence, there is a need to identify and quantify clinical predictors of prolonged mechanical ventilation (PMV).Predictors of PMV after pediatric cardiac surgery are investigated in several studies ([@A30391R1]-[@A30391R13]). Parameters such as the clinical condition of the patients and underlying disorders, factors related to surgical and anesthetic techniques, the postoperative ICU management protocols and certain postoperative complications including renal failure can influence the length of intubation ([@A30391R1]-[@A30391R13]). Identification of these parameters in each center could guide clinicians to choose the best management protocol. On the other hand there are some conflicts regarding the predictors among different medical centers.

2. Objectives {#sec143297}
=============

The current study aimed to describe PMV predictors in patients undergoing cardiac surgery for congenital heart disease in a tertiary center for pediatric cardiovascular diseases in Iran.

3. Patients and Methods {#sec143300}
=======================

The study was conducted from May to December 2014 at Rajaie cardiovascular, medical and research center, the center of excellence for pediatric cardiology and cardiovascular surgeries in Tehran, Iran. After approval of the study by the institutional research and ethics committee, all pediatric patients (less than a month -- 15 year old) admitted to pediatric ICU (PICU) after corrective or palliative cardiovascular surgery for congenital heart disease were consecutively included and patients who remained on mechanical ventilation for ≥ 72 hours and/or ≥ 7 days were defined as medium and extended prolonged mechanical ventilation (PMV) respectively. Children with neuromuscular disorders and flappy babies were excluded.Although the definition of PMV is arbitrary, in many similar studies extubation was usually achievable within three days even after complex cardiac procedures and PMV is defined as a mechanical ventilation duration more than 72 hours for medium PMV and seven days for extended PMV ([@A30391R1], [@A30391R3]). The demographic and clinical data and the variables probably related to PMV were recorded during the PICU stay. The recorded data included age, gender, weight, type of congenital heart disease, presence of pulmonary hypertension (mean pulmonary artery pressure more than 25 mmHg documented by catheterization or echocardiography), history of previous cardiac surgery, history of MV before surgery, surgical technique (palliative or corrective, on pump or off pump, etc.), intra operative variables including aortic cross clamp and cardiopulmonary bypass time, postoperative variables (inotropes type, dosage and duration and vasoactive inotropic score), laboratory data and complications including sepsis, heart failure, renal failure, respiratory complications, re intubation and death.

3.1. Calculation of Vasoactive Inotropic Score {#sec143298}
----------------------------------------------

The following inotropic agents were used in the current practice: dopamine, dobutamine, epinephrine, norepinephrine and milrinone. VIS was calculated as described by Davidson et al. and Gaies et al. ([@A30391R17]-[@A30391R19]).VIS (μg/kg/min) = dopamine dose (μg/kg/min) + dobutamine dose (μg/kg/min) + 100 × epinephrine dose (μg/kg/min) + 10 × milrinone dose (μg/kg/min) +10,000 × vasopressin dose (μg/kg/min) + 100 × Norepinephrine dose (μg/kg/min)

3.2. Statistical Analysis {#sec143299}
-------------------------

IBM SPSS Statistics 19.0 for Windows (IBM Corp., Armonk, NY, USA) was used for all the statistical analyses. All variables were assessed for normal distribution using Kolmogorov Smirnov test. Categorical variables were expressed as number and percentage and quantitative variables as mean (standard deviation) or median (interquartile range) for the variables not normally distributed. Student t-test or Mann--Whitney U test were used, as appropriate, to compare quantitative variables. Categorical data were compared by chi-square test. Binary logistic regression analysis was used for multivariate analysis. The Spearman\'s rank correlation coefficient was used to assess the correlation between not normally distributed interval variables. P \< 0.05 was considered significant.

4. Results {#sec143304}
==========

From May to December 2014, 300 patients, 56.7% male, were included in this study. The median (IQR) of age was 15 (5 - 39) months (from 10-day to 14-year-old). Thirty-three (11%) of patients were neonate and 139 (46.3%) patients were categorized as cyanotic congenital heart disease .Tetralogy of Fallot (TOF) was the most common diagnosis. 61 (20.3%) patients had a history of palliative surgeries (shunts or pulmonary artery banding) and 15(5%) patients had undergone redo operation. [Table 1](#tbl36801){ref-type="table"} depicts demographic and clinical findings of the study population.

###### Demographic Characteristics and Surgical Data of Study Population

  Variables                                 Values
  ----------------------------------------- --------------
  **Age, mo, mean (Interval)**              15 (5-39)
  **Weight, kg, mean (SD)**                 11 (9.7)
  **CBP time, min, mean (interval)**        81 (56-120)
  **AOX time, min, mean (interval)**        50 (30 - 75)
  **ICU stay, h, mean (interval)**          72 (48 -144)
  **MV duration, h, mean (interval)**       18 (8.75-48)
  **Gender, No. (%)**                       
  Male                                      170 (56.7)
  Female                                    130 (43.3)
  **Type of congenital anomaly, No. (%)**   
  Cyanotic                                  139 (46.3)
  Non-cyanotic                              161 (53.7)
  **Congenital heart disease, No. (%)**     
  Tetralogy of Fallout                      73 (24.3)
  VSD + PH                                  69 (23)
  ASD                                       25 (8.3)
  CAVSD                                     23 (7.7)
  Single ventricle + PS,TA                  29 (9.7)
  DORV + PS                                 10 (3.3)
  TGA                                       32 (10.7)
  TAPVC                                     6 (2)
  Aortic coarctation + AS + MS              16 (5.3)
  PDA + PH                                  8 (2.7)
  Other anomalies                           9 (3)
  Pulmonary hypertension                    129 (43)
  **History of operation, No. (%)**         
  Palliative                                61 (20.4)
  No history                                223 (74.6)
  Redo operation                            15 (5)
  Off pump                                  81 (27)
  On pump                                   219 (73)
  **Hypothermia during surgery, No. (%)**   
  Mild                                      183 (61)
  Moderate                                  1 (3)
  Severe                                    0
  Preoperative MV                           14 (4.6)

Abbreviations: AOX, aortic cross clamp; AS, aortic stenosis; ASD, atrial septal defect; CAVSD, complete atrioventricularseptal defect; CBP, cardiopulmonary bypass; DORV: double outlet right ventricle; ICU, intensive care unit; MS: mitral stenosis; MV: mechanical ventilation; PDA, pedusductusarteriosus; PH, pulmonary hypertension; PS, pulmonary stenosis; TA, truncusarteriosus; TAPVC, total anomalous pulmonary venous connection; TGA, transposition of great arteries.

4.1. Mechanical Ventilation Duration {#sec143301}
------------------------------------

The median duration (IQR) of MV was 18 hours (8.6 - 48 hours). From 2.5 hours to 43 days. The incidence of early extubation (≤ 6 hours after cardiac surgery) was 13.5% and 69.3% were extubated within 24 hours after surgery. Sixty (20%) patients remained on MV for more than 72 hours and 32 (10.7%) of them were mechanically ventilated for more than seven days. As expected the duration of ICU stay was more prolong and mortality was higher in patients with PMV ([Table 2](#tbl36802){ref-type="table"}).

###### Comparison of the Complications Between Patients With and Without Prolonged Mechanical Ventilation^[a](#fn39330){ref-type="table-fn"}^

  Variable                           Mechanical Ventilation D                                                                   
  ---------------------------------- -------------------------- ------------------ ---------- ----------------- --------------- ----------
  **Age (months)** ^**a**^           6 (0.6- 30)                24 (11 - 61.5)     \< 0.001   2 (0.6 - 12)      24 (11 - 60)    \< 0.001
  **Weight (Kg)** ^**a**^            6.5 (3.5-10.3)             10 (7.9 - 15)      \< 0.001   4.1 (3.2-9.7)     10 (7.5-14.5)   \< 0.001
  **Gender (No%)**                                                                                                              
  Male                               40 (66.7)                  130 (54.2)         0.08       21 (65.5)         149 (55.6)      0.2
  Female                             20(33.3)                   110 (45.8)         0.2        11 (34.4)         114 (44.4)      0.2
  **Type of congenital anomaly**                                                                                                
  Cyanotic                           38 (63.3)                  101 (42.1)         0.003      25 (78.1)         114 (42.5)      \< 0.001
  Non-cyanotic                       22 (36.7)                  139 (57.9)                    7 (21.9)          154 (57.5)      
  **Congenital heart Disease**                                                     0.003                                        0.003
  Tetralogy of fallot                10 (16.7)                  63 (26.3)                     5 (15.6)          68 (25.4)       
  VSD + PH                           14 (23.3)                  55 (22.9)                     2 (6.3)           67 (25)         
  ASD                                0                          25 (10.4)                     0                 25 (9.3)        
  CAVSD                              3 (5)                      20 (8.3)                      3 (9.4)           20 (7.5)        
  Single ventricle+PS, TA            7(11.7)                    22 (9.2)                      5 (15.6)          24 (9)          
  DORV+PS                            3(5)                       7 (2.9)                       2 (6.3)           8 (3)           
  TGA                                17(28.3)                   15 (6.3)                      10 (31.3)         22 (8.2)        
  TAPVC                              2(3.3)                     4 (1.7)                       2 (6.3)           4 (1.5)         
  Aortic coarctation + AS + MS       2(3.3)                     14 (5.8)                      1 (3.1)           15 (5.6)        
  PDA + PH                           1 (1.7)                    7 (2.9)                       1 (3.1)           7 (2.6)         
  **Other anomalies**                1 (1.7)                    8 (3.3)                       1 (3.1)           8 (3)           
  **Pulmonary hypertension (No%)**   33 (55)                    96 (40)            0.03       14 (43.8)         115 (42.9)      0.9
  **History of operation**                                                         0.1                                          0.3
  Palliative                         14 (23.3)                  47 (19.7)                     6 (18.8)          55 (20.6)       
  No history                         44 (75)                    179 (73.3)                    26 (81.3)         197 (73.8)      
  **Redo operation**                 2 (3.3)                    13 (5.4)                      0                 15 (5.6)        
  Off pump                           21 (35)                    60 (25)            0.1        13 (40.6)         68 (25.4)       0.06
  On pump                            39 (65)                    180 (75)                      19 (59.4)         200 (74.6)      
  **CBP time (minutes)** ^**a**^     119 (64 - 176)             75 (54 - 110)      \< 0.001   140 (77 - 172)    78 (55 - 115)   0.007
  **AOX time (minutes)** ^**a**^     73 (40 - 166)              43.5 (25.7 - 70)   0.003      76 (45 - 90)      44 (26 - 70)    0.02
  **Hypothermia during surgery**                                                   0.08                                         0.005
  Mild                               33 (84.6)                  150 (83.3)                    15 (78.9)         168 (84)        
  Moderate                           1 (2.6)                    0                             1 (5.3)           0               
  Severe                             \-                         \-                            \-                                
  **Preoperative MV**                6 (10)                     8 (3.3)            0.02       4 (12.5)          10 (3.7)        0.02
  **ICU stay (hours)** ^**a**^       264 (192 - 456)            48 (48 - 72)       \< 0.001   372 (29 4- 626)   48 (48 - 96)    \< 0.001
  **MV duration (hours)** ^**a**^    164 (88 -288)              12 (8 - 20.2)      \< 0.001   288 (240 - 528)   14 ( 8- 24)     \< 0.001

Abbreviations: LV: left Ventricle; PH: Pulmonary Hypertension; RV Right Ventricle.

^a^Data are presented as No. (%).

4.2. Predictors of PMV {#sec143302}
----------------------

[Table 3](#tbl36803){ref-type="table"} depicts a comparison between patients with and without PMV regarding demographic and clinical variables.

###### Comparison of Demographic, Clinical and Surgical Characteristics Between Patients With and Without Prolonged Mechanical Ventilation

  Complications^[a](#fn39336){ref-type="table-fn"}^   Mechanical Ventilation Duration                                                   
  --------------------------------------------------- --------------------------------- ----------- ---------- ----------- ------------ ----------
  **Delayed sternal closure**                         19 (32)                           8 (3.3)     \< 0.001   12 (37.5)   15 (5.6)     \< 0.001
  **Re-intubation**                                   25 (41.7)                         11 (4.6)    \< 0.001   11 (34.4)   25 (9.3)     \< 0.001
  **Heart failure**                                   20 (33.3)                         17 (7.1)    \< 0.001   14 (43.8)   23 (8.6)     \< 0.001
  **RV failure**                                      14 (23.3)                         5 (2.1)                10 (31.3)   9 (3.4)      
  **LV failure**                                      1 (1.7)                           10 (4.2)               1 (3.1)     10 (3.7)     
  **RV+LV failure**                                   5 (8.3)                           2 (0.8)                3 (9.4)     4 (1.5)      
  **Residual anomaly**                                21 (35)                           50 (21)     0.02       12 (37.5)   59 (22)      0.05
  **Sepsis**                                          9 (15)                            3 (1.3)     \< 0.001   7 (21.9)    5 (1.9)      \< 0.001
  **Positive blood culture**                          7 (11.7)                          0           \< 0.001   5 (15.6)    2 (0.7)      \< 0.001
  **Respiratory complications**                       43 (71.7)                         88 (36.7)   \< 0.001   28 (87.5)   103 (38.4)   \< 0.001
  **Pneumonia**                                       19 (31.7)                         3 (1.3)     \< 0.001   18 (56.3)   4 (1.5)      \< 0.001
  **Pneumothorax**                                    5 (8.3)                           3 (1.3)     0.002      3 (9.4)     5 (1.9)      0.01
  **Atelectasis**                                     8 (13.3)                          3 (1.3)     \< 0.001   4 (12.5)    7 (2.6)      0.01
  **Pleural effusion**                                31 (51.7)                         79 (33.1)   0.008      18 (56.3)   92 (34.5)    0.01
  **Pleural hemorrhages**                             4 (6.7)                           4 (1.7)     0.03       2 (6.3)     6 (2.2)      0.01
  **Postoperative PH**                                22 (36.7)                         56 (23.3)   0.03       12 (37.5)   66 (24.6)    0.1
  **Renal failure**                                   4 (6.7)                           1 (0.4)     0.001      3 (9.4)     2 (0.7)      \< 0.001
  **Reoperation for bleeding**                        4 (6.7)                           5 (2.1)     0.06       2 (6.3)     7 (2.6)      0.2
  **Lactate Level ≥4.2**                              16 (31)                           15 (7.1)    \< 0.001   12 (46.2)   19 (8)       \< 0.001
  **Death**                                           16 (26.7)                         19 (7.9)    \< 0.001   12 (37.5)   23 (8.6)     \< 0.001

Abbreviations: AS, aortic stenosis; ASD, atrial septal defect; Aox, aortic cross clamp; Cavsd: complete atrioventricularseptal defect; CBP, cardiopulmonary bypass; dorv: double-outlet right ventricle; ICU, intensive care unit; Ms, mitral stenosis, MV, mechanical ventilation; PDA, pedus ductus arteriosus; PH, pulmonary hypertension; PS, pulmonary stenosis; TA, t runcus arteriosus; TAPVC, total anomalous pulmonary venous connection; TGA, transposition of great arteries.

^a^Data presented as median (IQR).

As shown in [Table 2](#tbl36802){ref-type="table"}, age, weight, presence of cyanotic heart disease, pulmonary hypertension (PH) and mechanical ventilation before surgery were associated with PMV. PMV was also more prevalent in patients undergoing surgery for complex congenital heart lesions.There was no association between gender, history of surgery (palliative, corrective, and redo surgery) and PMV (P \> 0.05). The hypothermia was used during surgery in 61.3% of the patients, no association was found between using hypothermia and mechanical ventilation duration more than 72 hours .However, MV duration more than seven days was associated with hypothermia during surgery (P = 0.005) Although there was no correlation between the on pump or off pump surgery and PMV, cardiopulmonary bypass time (CPB time) and aortic cross clamp (AOX) time were significantly longer among patients with PMV (P \< 0.001). As expected the CPB and AOX time were also longer in patients who developed heart failure (HF) manifestations. The median (IQR) of CBP time was 79 (55 - 114) versus 125 (72.5 - 169) minutes in patients without and with HF respectively, and the median (interquartile range) of AOX time was 44 (26.7 - 70) versus 73 (35 - 100) minutes in patients without and with HF respectively (P \< 0.001 for both CBP and AOX time). The complications of surgery are shown in [Table 3](#tbl36803){ref-type="table"}. As expected the PMV was associated with more complications and mortality. Among all complications only reoperation for bleeding had no association with PMV in this study (P \> 0.05).The lactate level was significantly correlated with PMV. As shown in [Table 2](#tbl36802){ref-type="table"}, 31% and 46% of patients with PMV more than 72 hours and seven days had a high lactate level ( \> 4.2) which were significantly higher than those of the patients not on PMV (P \< 0.001). [Table 4](#tbl36804){ref-type="table"} shows inotropes used in the study population. There was an association between the numbers of inotropes and mechanical ventilation duration (P \< 0.001). Patients with PMV received more inotropes. Fifty three percent of the patients, extubated before 72 hours were on only one inotrope whereas 43.3% of the patients with PMV received at least three different inotropes.

###### Comparison of Inotropes Type, Dosages and Vasoactive Inotropic Score Between Patients with and Without Prolonged Mechanical Ventilation

                       Mechanical Ventilation Duration                                                                                                                                                                                                      
  -------------------- --------------------------------- ------------------------------------------ ----------- ------------------------------------------ ---------- ------------ ------------------------------------------ ----------- ----------------- ----------
  **Inotrope**         NO (%)                            Dose^[a](#fn39332){ref-type="table-fn"}^   NO (%)      Dose^[a](#fn39332){ref-type="table-fn"}^              NO (%)       Dose^[a](#fn39332){ref-type="table-fn"}^                                 
  **Milrinone**        172 (72)                          0.5 (0.5 - 0.5)                            46 (76.7)   0.5 (0.5 - 0.5)                            0.4        194 (72.4)   0.5 (0.5 - 0.5)                            24 (75)     0.5 (0.5-0.5)     0.7
  **Dopamine**         18 (7.5)                          6 (5 - 7.5)                                25 (41.7)   5 (5 - 7.5)                                \< 0.001   30 (11.2)    6 (5-7.5)                                  13 (40.6)   5 (5-7)           \< 0.001
  **Dobutamine**       14 (5.8)                          5 (5-7)                                    27 (45)     5 (5-7)                                    \< 0.001   22 (8.2)     5 (5 - 7.5)                                19 (59.4)   5 (5-10)          \< 0.001
  **Epinephrine**      67 (27.9)                         0.05 (0.05-0.10)                           42 (70)     0.1 (0.05-0.1)                             \< 0.001   83 (31)      0.01 (0.01-0.1)                            26 (81.3)   0.10 (0.05-0.1)   \< 0.001
  **Norepinephrine**   3 (1.3)                           0.05 (0.05-0.10)                           \-          \-                                         \-         3 (1.1)      0.05 (0.05-0.01)                           \-          \-                \-
  **VIS**                                                5 (5 - 10)                                             15 (10 - 22.5)                             \< 0.001                5 (5 - 10)                                             18.5 (10 - 25)    \< 0.001

Abbreviation: VIS: Vasoactive Inotropic Score.

^a^The drug dosage in microgram/kilogram/minutes presented as median (IQR).

Regarding the inotrope dosages and intubation duration, there was only a weak correlation between milrinone dose and intubation duration (Spearman's rho = 0.22, P = 0.001).However, VIS was significantly correlated with intubation duration (Spearman's rho = 0.5, P \< 0.001) and was higher among patients remaining on MV more than 72 hours or seven days ([Table 4](#tbl36804){ref-type="table"}). VIS was also moderately correlated with the duration of ICU stay (Spearman's rho = 0.4, P \< 0.001).

4.3. Independent Predictors of PMV {#sec143303}
----------------------------------

A multivariate logistic regression model was applied to determine the independent predictors of PMV and showed delayed sternal closure, sepsis, re-intubation, VIS and the number of inotropes were independent predictors for MV more than 72 hours. According to the multivariate analysis younger age, lower weight, the presence of pulmonary hypertension before surgery and presence of some complications such as heart failure, respiratory complications and renal failure accompanied by delayed sternal closure, VIS and the number of inotropes can be considered as independent predictors of mechanical ventilation more than seven days. ([Tables 5](#tbl36805){ref-type="table"} and [6](#tbl36806){ref-type="table"}).

###### Multivariable Analysis to Investigate the Adjusted Associations Between Prolonged Mechanical Ventilation and Some Predictors

                                Coefficient (β)   P Value   Odd Ratio (CI 95%)
  ----------------------------- ----------------- --------- -----------------------
  **VIS**                       -0.125            .012      0.883 (0.801 - 0.973)
  **Delayed sternal closure**   -2.951            .001      0.052 (0.01 - 0.280)
  **Reintubation**              -3.076            .000      0.046 (0.01 - 0.205)
  **Sepsis**                    -3.061            .069      0.047 (0.002 - 1.26)
  **Inotrope using**            2.426             .000      11.3 (3.5 - 36.6)

###### Multivariable Analysis to Investigate the Adjusted Associations Between Prolonged Mechanical Ventilation and Some Predictors

                                  Coefficient (β)   P Value   Odd Ratio (CI 95%)
  ------------------------------- ----------------- --------- ---------------------
  **Age**                         0.163             .007      1.2 (1.04 -- 1.32)
  **Weight**                      -1.040            .004      0.35 (.17 - .71)
  **PH**                          4.530             .007      92.8 (3.5 - .2448)
  **VIS**                         -0.169            .026      0.84 (.73 -- .98)
  **Delayed sternal closure**     -2.366            .042      0.09 (.01 - .9)
  **Heart failure**               3.870             .005      47.9 (3.1- .735)
  **Respiratory complications**   -7.473            .028      0.001 (.0001 - .45)
  **Renal Failure**               -2.877            .071      0.06 (.002 - .1.3)
  **Inotrope using**              2.126             .008      8.4 (1.7 - .40.6)

Abbreviations: PH; Pulmonary hypertension, VIS; vasoactive inotropic score.

5. Discussion {#sec143306}
=============

In the current study about 70% of the patients were extubated within 24 hours after cardiac surgery. The MV median was 18 hours, 20% of the patients had a MV duration more than 72 hours and the incidence of MV duration more than seven days was about 11% in the study population which was similar to those of the previous reports. The incidence of PMV in young children after congenital heart surgery was 10% - 19% ([@A30391R4]), and in adult population after cardiovascular surgery was 3% - 22% ([@A30391R20]). The incidence of PMV in Shi et al. ([@A30391R3]) and Szekely et al. ([@A30391R1]) were 35.4% and 25% respectively, and in the study by Polito et al. ([@A30391R6]) 11% of pediatric patients undergoing cardiac surgery remained intubated for more than seven days.Recently, early extubation is being considered as a safe strategy after cardiac surgery in many centers ([@A30391R1]-[@A30391R13]). However, there are conflicting data regarding the definition and the predictors of PMV in different studies ([@A30391R1]-[@A30391R9]). It is shown that even after complex heart surgeries, extubation is usually achievable before 72 hours ([@A30391R1]). In the study by Davis et al.([@A30391R8]) 47% of pediatric patients were extubated within 24 hours after the cardiac surgery. In their study heart failure and pulmonary hypertension were suggested as the main reasons for failed early extubation. The median duration for MV in the study by Marwali al. was 12 hours (0 - 25 days) ([@A30391R2]). Results of the current study showed that delayed sternal closure, sepsis, re-intubation, VIS and numbers of inotropes would be independent predictors for MV more than 72 hours. The independent predictors of MV for more than a week were age, weight, pulmonary hypertension before surgery and presence of some complications such as heart failure, respiratory complications and renal failure accompanied by delayed sternal closure, VIS and numbers of inotropes. Although univariate analyses show similarities in the predictors for PMV between different studies ([@A30391R1]-[@A30391R13]), the multivariate analyses show that independent predictors would somehow be different in different centers. One possible reason for these differences could be differences in institutional protocols in the preoperative and ICU management of pediatric patients after cardiac surgery. However, some factors such as age, pulmonary hypertension, infections particularly respiratory infections and heart failure were common among different investigations ([@A30391R1]-[@A30391R9]).In a similar study by Shi et al.([@A30391R3]) nosocomial pneumonia, fluid imbalance and low cardiac output syndromes were independently associated with PMV (MV ≥ 72 hours). Marwali et. al.([@A30391R2]) reported that younger age, longer cardiopulmonary bypass time and greater severity of congenital anomaly could be independently associated with PMV. Szekely et al.([@A30391R1]) considered that the MV duration more than 61 hours and seven days as medium and long PMV, respectively. They concluded that the presence of complications such as heart failure, infection, renal failure and arrhythmias were independent predictors for both medium and long PMV. Young age is known as an important predictor of PMV and ICU stay ([@A30391R1], [@A30391R2], [@A30391R5], [@A30391R21], [@A30391R22]). The incidence of PMV in infants undergoing surgery for congenital heart disease is estimated 10%-19% ([@A30391R4]). Shu et al. showed a failed extubation rate of 13.2% after cardiac surgery for CHD in pediatric patients with a mean age of 6±4 months ([@A30391R4]). They also showed that preoperative pulmonary hypertension and postoperative pneumonia were independent factors to predict failed extubation ([@A30391R4]). The infants with CHD are physiologically different from the older children or the adults. They may be low birth weight, malnourished and most of them have a history of frequent infectious episodes because of depressed immunity. Therefore, they tend to have limited cardiorespiratory reserve and are prone to PMV ([@A30391R1], [@A30391R2], [@A30391R5], [@A30391R21], [@A30391R22]). Many investigators suggest preoperative pulmonary hypertension and respiratory complications including postop pneumonia as important and independent risk factors for failed extubation in children undergoing cardiac surgery for CHD ([@A30391R4], [@A30391R5], [@A30391R9]). After corrective surgery of congenital anomalies in patients with left-to-right shunt the pulmonary arterial pressure decreases, partially or totally. However, these patients are prone to pulmonary hypertensive crisis after surgery which may be due to hypoperfusion of pulmonary tissue during cardiopulmonary bypass .The pulmonary compliance will decrease in patients with pulmonary hypertension crisis and prone them to respiratory complications and PMV ([@A30391R4], [@A30391R5]).Cardiac dysfunction is another important predictor for PMV after congenital heart disease surgery. ([@A30391R2], [@A30391R3]) Many children with congenital heart anomalies, particularly those with complex ones have limited cardiac reserve which may get worse during CPB ([@A30391R22]).The occurrence of heart failure and low output state syndrome after congenital heart surgery is multi factorial and depends on the severity of cardiac dysfunction before surgery, aortic cross clamp time, CPB time and myocardial preservation measures during surgery ([@A30391R1], [@A30391R3]). With persistence, the heart failure clinical manifestations, and discontinuing the inotrope support will be difficult and using multiple and high dose inotropes might induce more myocardial damages ([@A30391R1], [@A30391R3], [@A30391R22]). Although CPB and AOX time were not independently associated with PMV in the current study, using multiple inotropes, VIS and presence of heart failure were independent predictors of PMV.The presence of conflicting data regarding the independent PMV predictors shows that complex systemic and cardiopulmonary interactions contribute to this issue and it is impossible to have a universal list of risk factors for this multifactorial phenomenon. Authors believe that the possible predictors should be assessed in each center and each pediatric cardiology center should have its own protocol in the perioperative management of these patients.

5.1. Study Limitations {#sec143305}
----------------------

The study considered different age groups all together (neonate to 15 years).It was better to perform a subgroup analysis. Some risk factors mentioned in other studies such as nutritional status and other therapeutic interventions were not considered (antibiotics, non-invasive ventilation, diuretics, etc.). In conclusion, younger age, lower weight, the presence of heart failure and using higher doses of inotropes and several complications particularly respiratory infections would be considered as important factors to predict PMV in children undergoing cardiac surgery for congenital anomalies. The results of the current study indicate the need for a good administration program to direct specific protocols for the preoperative management of patients undergoing congenital heart surgeries. Further studies are recommended to assess the role of different therapeutic measures of this issue.
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